Literature DB >> 3973007

Muscle acetylcholine receptor loss in murine experimental autoimmune myasthenia gravis: correlated with cellular, humoral and clinical responses.

P Christadoss, J Lindstrom, S Munro, N Talal.   

Abstract

An extensive analysis of the relationship between immunological parameters and clinical responses and biochemical loss of muscle acetylcholine receptors (AChR) was performed in murine experimental autoimmune myasthenia gravis. The onset of clinical muscle weakness correlated strongly with the onset of significant muscle AChR loss. Mice with clinical muscle weakness had greater amount of muscle AChR loss. There was no correlation between the concentration of anti-AChR antibodies and the presence of clinical muscle weakness or amount of muscle AChR loss. However, the kinetics of autoantibody response correlated well with that of muscle AChR loss.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973007     DOI: 10.1016/s0165-5728(85)80045-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

Review 1.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 2.  Immunopathogenesis and treatment of myasthenia gravis.

Authors:  A I Levinson; B Zweiman; R P Lisak
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

3.  Immature Exosomes Derived from MicroRNA-146a Overexpressing Dendritic Cells Act as Antigen-Specific Therapy for Myasthenia Gravis.

Authors:  Weifan Yin; Song Ouyang; Zhaohui Luo; Qiuming Zeng; Bo Hu; Liqun Xu; Yuan Li; Bo Xiao; Huan Yang
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

4.  Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice.

Authors:  Huan Yang; Elzbieta Goluszko; Chella David; David K Okita; Bianca Conti-Fine; Teh-sheng Chan; Mathilde A Poussin; Premkumar Christadoss
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

5.  Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.

Authors:  F D Shi; X F Bai; H L Li; Y M Huang; P H Van der Meide; H Link
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

6.  Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.

Authors:  B Balasa; C Deng; J Lee; L M Bradley; D K Dalton; P Christadoss; N Sarvetnick
Journal:  J Exp Med       Date:  1997-08-04       Impact factor: 14.307

7.  Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis (EAMG).

Authors:  Y M Graus; P J van Breda Vriesman; M H de Baets
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

8.  Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis.

Authors:  P Christadoss; J M Lindstrom; R W Melvold; N Talal
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

9.  Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.

Authors:  Gregory Kordas; George Lagoumintzis; Sotirios Sideris; Konstantinos Poulas; Socrates J Tzartos
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.